Articles from Claritev

MCLEAN, Va., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the third quarter ended September 30, 2026.

MCLEAN, Va., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and insights company, today announced that members of its management team will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Wednesday, November 11, 2026, in New York, including a presentation at 3:30 p.m. ET.

New AI-enabled innovation translates complex government-required public transparency data into a flexible, market-informed, and explainable methodology for evaluating reimbursement strategies.

Board gains deep public sector healthcare and financial leadership expertise to support Claritev's growth strategy

MCLEAN, Va., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent, and fair for all, announced today that it will release its third quarter fiscal year 2026 financial results prior to market open on Monday, November 9, 2026, and hold a conference call at 8:00 am Eastern Time.

Claritev, a healthcare technology, data, and insights company, today announced that Fernando Schwartz, Ph.D., Senior Vice President and Chief AI Officer, has been named to the DataIQ 100 North America list for 2026, recognizing leaders applying data and artificial intelligence to drive measurable impact across industries.